Meningococcal vaccine

File:Menitorix vaccine.jpg

Vials of Meningococcal Vaccine.

The Meningococcal Vaccine refers to any vaccine derived from Neisseria meningitidis, used for the prophylaxis against meningitis. These vaccines can be in whole-cell or acellular forms and are crucial in preventing meningococcal disease, a serious bacterial infection.

History of Meningococcal Vaccine

The development of meningococcal vaccines began in the 20th century, with significant advancements over the decades. The first large-scale use of a meningococcal vaccine occurred in the 1960s.

Types of Meningococcal Vaccines

There are several types of meningococcal vaccines available:

MenACWY Vaccines

File:MRNA-vaccine-infographic-EL (1).png

MenACWY Vaccine.

MenACWY vaccines are conjugate vaccines that protect against four serogroups of Neisseria meningitidis—A, C, W, and Y. Examples include Menactra and Menveo.

MenB Vaccines

File:Vaccines UK 12 months 2022.jpg

MenB Vaccine.

MenB vaccines, like Bexsero and Trumenba, provide protection against serogroup B meningococcal bacteria.

Usage and Administration

Meningococcal vaccines are recommended for people at increased risk for meningococcal disease, including:

• Adolescents
• Travelers to certain parts of the world
• Persons with specific medical conditions

Effectiveness and Protection

These vaccines are highly effective in preventing meningococcal disease caused by serogroups covered by the vaccine. They can significantly reduce the risk of infection.

Side Effects and Safety

Common side effects include redness and pain at the injection site. Severe allergic reactions are rare. Overall, the vaccines are considered safe and effective.

External Links

• CDC - Meningococcal Vaccination
• WHO - Meningococcal meningitis